MY134582A - New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments - Google Patents

New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments

Info

Publication number
MY134582A
MY134582A MYPI20030303A MYPI20030303A MY134582A MY 134582 A MY134582 A MY 134582A MY PI20030303 A MYPI20030303 A MY PI20030303A MY PI20030303 A MYPI20030303 A MY PI20030303A MY 134582 A MY134582 A MY 134582A
Authority
MY
Malaysia
Prior art keywords
medicaments
manufacture
new
acid esters
fluorenecarboxylic acid
Prior art date
Application number
MYPI20030303A
Inventor
Germeyer Dr Sabine
Meissner Helmut
Morschhauser Gerd
Pestel Dr Sabine
Dr Michael P Pieper
Pohl Dr Gerald
Reichl Dr Richard
Speck Dr Georg
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY134582A publication Critical patent/MY134582A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. ***e

Abstract

THE PRESENT INVENTION RELATES TO NEW FLUORENECARBOXYLIC ACID ESTERS OF GENERAL FORMULA 1 WHERIN X- AND THE GROUPS A,R,R1,R2,R3,R3',R4 AND R4' MAY HAVE THE MEANINGS GIVEN IN THE CLAIMS AND IN THE SPECIFICATION , PROCESSES FOR THE MANUFACTURE THEREOF AND THE USE THEREOF AS MEDICAMENTS.
MYPI20030303A 2002-01-31 2003-01-29 New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments MY134582A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10203741A DE10203741A1 (en) 2002-01-31 2002-01-31 New fluorene carboxylic acid esters, process for their preparation and their use as medicaments

Publications (1)

Publication Number Publication Date
MY134582A true MY134582A (en) 2007-12-31

Family

ID=27588159

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20030303A MY134582A (en) 2002-01-31 2003-01-29 New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments

Country Status (29)

Country Link
EP (2) EP1561751A1 (en)
JP (1) JP4484522B2 (en)
KR (1) KR100950869B1 (en)
CN (1) CN100348598C (en)
AR (1) AR038379A1 (en)
AT (1) ATE299880T1 (en)
AU (1) AU2003210172C1 (en)
BR (1) BR0307294A (en)
CA (1) CA2472149C (en)
DE (2) DE10203741A1 (en)
EA (1) EA006966B1 (en)
EC (1) ECSP045209A (en)
ES (1) ES2245443T3 (en)
HK (1) HK1082376A1 (en)
HR (1) HRP20040690B1 (en)
IL (1) IL162527A0 (en)
ME (1) MEP43408A (en)
MX (1) MXPA04007245A (en)
MY (1) MY134582A (en)
NO (1) NO328929B1 (en)
NZ (1) NZ534784A (en)
PE (1) PE20031029A1 (en)
PL (1) PL209037B1 (en)
PT (1) PT1472251E (en)
RS (1) RS50918B (en)
TW (1) TWI352077B (en)
UA (1) UA78544C2 (en)
UY (1) UY27633A1 (en)
WO (1) WO2003064419A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316996T3 (en) * 2003-07-28 2009-04-16 Boehringer Ingelheim International Gmbh MEDICINES FOR INHALATION, UNDERSTANDING BETAMIMETICS AND AN ANTI-POLINERGIC AGENT.
WO2005013967A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
ES2326320T3 (en) * 2003-07-28 2009-10-07 Boehringer Ingelheim International Gmbh INHALATION DRUGS THAT INCLUDE STEROIDS AND NEW ESTER OF FLUORENCARBOXILIC ACID.
CA2534120C (en) * 2003-07-31 2012-09-11 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising anticholinergics and a betamimetic
DE102004001607A1 (en) * 2004-01-09 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations based on scopin or tropic acid esters with EGFR kinase inhibitors
US7507745B2 (en) * 2004-02-20 2009-03-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
CA2552903A1 (en) * 2004-02-20 2005-09-01 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on anticholinergics and pegsunercept
DE102004016179A1 (en) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Compounds for the treatment of proliferative processes
US20060034776A1 (en) * 2004-08-10 2006-02-16 Boehringer Ingelheim International Gmbh Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics
DE102004038885A1 (en) * 2004-08-10 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
ES2322148T3 (en) * 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG MEDICINES CONTAINING ANTI-POLINERGIC FOR TREATMENT IN URINARY ROADS.
DE102005001297A1 (en) * 2005-01-12 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
JP2008530177A (en) * 2005-02-16 2008-08-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Pharmaceutical composition comprising an anticholinergic and etiprednol
WO2006094924A2 (en) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
WO2006128847A2 (en) * 2005-05-31 2006-12-07 Boehringer Ingelheim International Gmbh Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
DE102005030733A1 (en) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
US20090324510A1 (en) 2006-08-07 2009-12-31 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
UY30550A1 (en) 2006-08-22 2008-03-31 Boehringer Ingelheim Int NEW BETA-AGANISTAS ENANTIOMÉRICAMENTE PUROS, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS
EP1925296A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
EP1997819A1 (en) * 2007-05-25 2008-12-03 Boehringer Ingelheim Pharma GmbH & Co. KG Method for manufacturing scopinium esters
ES2569359T3 (en) 2007-07-06 2016-05-10 Vectura Delivery Devices Limited Inhaler
US20100234411A1 (en) * 2007-07-18 2010-09-16 Boehringer Ingelheim Intermational Gmbh New Combination for the Treatment of Respiratory Diseases
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2093219A1 (en) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Crystalline enantiomer free salt form of a betamimetic and its use as medicine
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
CN102876318B (en) * 2012-09-28 2014-07-16 宁波大学 Fluorene acid ester fluorescent material and preparation method thereof
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2221828A (en) * 1936-04-25 1940-11-19 Merck & Co Inc Esters of amino alcohols with 9-hydroxyfluorene-9-carboxylic acid and processes for their production
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
AR038379A1 (en) 2005-01-12
DE50300813D1 (en) 2005-08-25
UA78544C2 (en) 2007-04-10
MXPA04007245A (en) 2004-10-29
JP4484522B2 (en) 2010-06-16
JP2005516067A (en) 2005-06-02
TWI352077B (en) 2011-11-11
NZ534784A (en) 2005-08-26
KR20040081166A (en) 2004-09-20
UY27633A1 (en) 2003-08-29
HK1082376A1 (en) 2006-05-04
IL162527A0 (en) 2005-11-20
TW200302817A (en) 2003-08-16
ATE299880T1 (en) 2005-08-15
CN100348598C (en) 2007-11-14
CA2472149C (en) 2011-01-11
AU2003210172C1 (en) 2009-09-24
EP1561751A1 (en) 2005-08-10
CN1625557A (en) 2005-06-08
HRP20040690B1 (en) 2012-09-30
EP1472251B1 (en) 2005-07-20
NO20043612L (en) 2004-08-30
PL209037B1 (en) 2011-07-29
AU2003210172B2 (en) 2009-04-02
RS65604A (en) 2006-12-15
PT1472251E (en) 2005-10-31
RS50918B (en) 2010-08-31
CA2472149A1 (en) 2003-08-07
EA200400878A1 (en) 2005-02-24
DE10203741A1 (en) 2003-08-14
HRP20040690A2 (en) 2005-10-31
ECSP045209A (en) 2004-09-28
EA006966B1 (en) 2006-06-30
WO2003064419A1 (en) 2003-08-07
PE20031029A1 (en) 2004-01-27
PL369396A1 (en) 2005-04-18
KR100950869B1 (en) 2010-04-06
BR0307294A (en) 2004-12-21
EP1472251A1 (en) 2004-11-03
MEP43408A (en) 2011-02-10
ES2245443T3 (en) 2006-01-01
NO328929B1 (en) 2010-06-21

Similar Documents

Publication Publication Date Title
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
UA85708C2 (en) Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases
CA2425560A1 (en) Anticholinergics, processes for preparing them and their use as pharmaceutical compositions
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
TW200621779A (en) Process for the manufacture of dihydropteridinones
HK1087022A1 (en) Dpp-iv inhibitors
MY136034A (en) New medicaments for the treatment of chronic obstructive pulmonary disease
RS115004A (en) Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof
YU45403A (en) Novel 1,2-diphenyl azetidinones, method for producing the same medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
DE50304569D1 (en) XANTHENCARBONIC ACID ESTERS OF TROPENOL AND SCOPINS AS M3 ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DRUGS
MX2008014101A (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments.
HRP20050465A2 (en) Carbamic acid esters with an anticholinergic action
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
RS20050719A (en) Novel diphenyl azetidinone with improved phzsiolo gical characteristics, corresponding production method, medicaments containing said compound and use of the latter
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
GEP20084376B (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
MXPA03009548A (en) Arylsulfonamides as antiviral agents.
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
SE0101038D0 (en) Novel compounds
WO2008023003A8 (en) Drug combinations for treating airway diseases
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
GEP20074100B (en) Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising the same
DE60112241D1 (en) PROCESS AND INTERMEDIATE COMPOUNDS FOR THE PRODUCTION OF IMIDAZOPYRIDINES